(Circulation. 1995;92:898-903.)
© 1995 American Heart Association, Inc.
Articles |
From the Divisions of Cardiology (Y.O., T.E.P., H.S.S., D.G.H.) and Hematology/Oncology (R.R.S., J.N.W.), Emory University School of Medicine, and the Atlanta Veterans Administration Medical Center (D.G.H.), Atlanta, Ga.
Correspondence to David G. Harrison, MD, Cardiology Division, PO Box Drawer LL, Emory University School of Medicine, Atlanta, GA 30322.
Background We have shown that hypercholesterolemia increases vascular superoxide anion (O2-) production, which could be responsible for augmented inactivation of endothelium-derived vascular relaxing factor. We sought to determine whether this increased vascular O2- production is due to infiltration of macrophages into the intima and whether dietary treatment of hypercholesterolemia normalizes O2- production.
Methods and Results A specific and sensitive assay for O2- based on chemiluminescence of lucigenin was used; the amount of O2- produced by vascular ring segments was quantified based on known quantities of O2- produced by xanthinexanthine oxidase standards. O2- production of aortic segments from normal rabbits (n=9), cholesterol-fed rabbits (1% cholesterol diet for 1 month, n=7), and rabbits fed a 1% cholesterol diet for 1 month followed by a normal diet for 1 month (regression rabbits, n=5) was measured. At the end of these diets, serum cholesterol levels were 1.5±0.2, 26.0±3.9, and 1.8±0.5 mmol/L (58±6, 1000±150, and 71±19 mg/dL) in the normal, cholesterol-fed, and regression animals, respectively. Vessels from normal rabbits with endothelium produced 0.32±0.06 nmol O2-/mg dry wt per minute, whereas those without endothelium produced approximately twice as much O2- (0.66±0.12 nmol O2- mg dry wt per minute. Vessels with endothelium from cholesterol-fed rabbits produced 4.5-fold more O2- than vessels from normal animals. This increased production of O2- was normalized by endothelial removal. This increased production of O2- was not due to infiltration of macrophages in the intima, because there was no correlation between vascular O2- production and macrophage infiltration assessed by immunohistochemistry with use of a specific antibody against rabbit macrophage. O2- production by vessels from regression rabbits was similar to that observed in normal animals, and as in the normal rabbits, endothelial removal increased O2- production. Aortic rings from these animals also were studied in organ chambers. Dietary lowering of cholesterol dramatically improved vasodilator responses to acetylcholine and A23187 (P<.05 versus cholesterol-fed rabbits).
Conclusions Dietary lowering of cholesterol not only improves endothelium-dependent vascular relaxation but also normalizes endothelial O2- production. Decreases of O2- production by dietary lowering of cholesterol not only may improve vasomotor control but also may improve other aspects of vascular integrity in atherosclerosis.
Key Words: hypercholesterolemia macrophages free radicals endothelium-derived factors vasodilation
This article has been cited by other articles:
![]() |
C. S. Packer Soluble guanylate cyclase (sGC) down-regulation by abnormal extracellular matrix proteins as a novel mechanism in vascular dysfunction: Implications in metabolic syndrome Cardiovasc Res, February 1, 2006; 69(2): 302 - 303. [Full Text] [PDF] |
||||
![]() |
S. L. Bledsoe, J. C. Barr, R. T. Fitzgerald, A. T. Brown, F. H. Faas, J. F. Eidt, and M. M. Moursi Pravastatin and Clopidogrel Combined Inhibit Intimal Hyperplasia in a Rat Carotid Endarterectomy Model Vascular and Endovascular Surgery, January 1, 2006; 40(1): 49 - 57. [Abstract] [PDF] |
||||
![]() |
M. Fujita, T. Kuwaki, K. Ando, and T. Fujita Sympatho-Inhibitory Action of Endogenous Adrenomedullin Through Inhibition of Oxidative Stress in the Brain Hypertension, June 1, 2005; 45(6): 1165 - 1172. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Landmesser, F. Bahlmann, M. Mueller, S. Spiekermann, N. Kirchhoff, S. Schulz, C. Manes, D. Fischer, K. de Groot, D. Fliser, et al. Simvastatin Versus Ezetimibe: Pleiotropic and Lipid-Lowering Effects on Endothelial Function in Humans Circulation, May 10, 2005; 111(18): 2356 - 2363. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Gutterman, H. Miura, and Y. Liu Redox Modulation of Vascular Tone: Focus of Potassium Channel Mechanisms of Dilation Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 671 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Violi, L Loffredo, L Musella, and A Marcoccia Should antioxidant status be considered in interventional trials with antioxidants? Heart, June 1, 2004; 90(6): 598 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kawashima and M. Yokoyama Dysfunction of Endothelial Nitric Oxide Synthase and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., June 1, 2004; 24(6): 998 - 1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ishikawa, K. Y. Stokes, J. H. Zhang, A. Nanda, and D. N. Granger Cerebral Microvascular Responses to Hypercholesterolemia: Roles of NADPH Oxidase and P-Selectin Circ. Res., February 6, 2004; 94(2): 239 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Y. Stokes, E. C. Clanton, J. L. Gehrig, and D. N. Granger Role of interleukin 12 in hypercholesterolemia-induced inflammation Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2623 - H2629. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pierre-Paul and V. Gahtan Noncholesterol-Lowering Effects of Statins Vascular and Endovascular Surgery, September 1, 2003; 37(5): 301 - 313. [Abstract] [PDF] |
||||
![]() |
K. Y. Stokes, E. C. Clanton, K. P. Clements, and D. N. Granger Role of Interferon-{gamma} in Hypercholesterolemia-Induced Leukocyte-Endothelial Cell Adhesion Circulation, April 29, 2003; 107(16): 2140 - 2145. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yan, D. Kim, T. Aizawa, and B. C. Berk Functional Interplay Between Angiotensin II and Nitric Oxide: Cyclic GMP as a Key Mediator Arterioscler. Thromb. Vasc. Biol., January 1, 2003; 23(1): 26 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kalinina, A. Agrotis, E. Tararak, Y. Antropova, P. Kanellakis, O. Ilyinskaya, M. T. Quinn, V. Smirnov, and A. Bobik Cytochrome b558-Dependent NAD(P)H Oxidase-Phox Units in Smooth Muscle and Macrophages of Atherosclerotic Lesions Arterioscler. Thromb. Vasc. Biol., December 1, 2002; 22(12): 2037 - 2043. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Aikawa, S. Sugiyama, C. C. Hill, S. J. Voglic, E. Rabkin, Y. Fukumoto, F. J. Schoen, J. L. Witztum, and P. Libby Lipid Lowering Reduces Oxidative Stress and Endothelial Cell Activation in Rabbit Atheroma Circulation, September 10, 2002; 106(11): 1390 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Palinski and S. Tsimikas Immunomodulatory Effects of Statins: Mechanisms and Potential Impact on Arteriosclerosis J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1673 - 1681. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. van Etten, E. J.P. de Koning, M. L. Honing, E. S. Stroes, C. A. Gaillard, and T. J. Rabelink Intensive Lipid Lowering by Statin Therapy Does Not Improve Vasoreactivity in Patients With Type 2 Diabetes Arterioscler. Thromb. Vasc. Biol., May 1, 2002; 22(5): 799 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Hathaway, D. D. Heistad, D. J. Piegors, and F. J. Miller Jr Regression of Atherosclerosis in Monkeys Reduces Vascular Superoxide Levels Circ. Res., February 22, 2002; 90(3): 277 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. K. Kim, M.-S. Lee, S. M. Son, I. J. Kim, W. S. Lee, B. Y. Rhim, K. W. Hong, and C. D. Kim Vascular NADH Oxidase Is Involved in Impaired Endothelium-Dependent Vasodilation in OLETF Rats, a Model of Type 2 Diabetes Diabetes, February 1, 2002; 51(2): 522 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-M. Go, A.-L. Levonen, D. Moellering, A. Ramachandran, R. P. Patel, H. Jo, and V. M. Darley-Usmar Endothelial NOS-dependent activation of c-Jun NH2- terminal kinase by oxidized low-density lipoprotein Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2705 - H2713. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Landmesser and D. G. Harrison Oxidant Stress as a Marker for Cardiovascular Events: Ox Marks the Spot Circulation, November 27, 2001; 104(22): 2638 - 2640. [Full Text] [PDF] |
||||
![]() |
R. A. Beswick, A. M. Dorrance, R. Leite, and R. C. Webb NADH/NADPH Oxidase and Enhanced Superoxide Production in the Mineralocorticoid Hypertensive Rat Hypertension, November 1, 2001; 38(5): 1107 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Thakur, T. Hayashi, D. Sumi, H. Kano, T. Tsunekawa, and A. Iguchi HMG-CoA reductase inhibitor stabilizes rabbit atheroma by increasing basal NO and decreasing superoxide Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H75 - H83. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Martinez-Gonzalez, B. Raposo, C. Rodriguez, and L. Badimon 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition Prevents Endothelial NO Synthase Downregulation by Atherogenic Levels of Native LDLs : Balance Between Transcriptional and Posttranscriptional Regulation Arterioscler. Thromb. Vasc. Biol., May 1, 2001; 21(5): 804 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. Dzau Tissue Angiotensin and Pathobiology of Vascular Disease : A Unifying Hypothesis Hypertension, April 1, 2001; 37(4): 1047 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Dobrian, M. J. Davies, S. D. Schriver, T. J. Lauterio, and R. L. Prewitt Oxidative Stress in a Rat Model of Obesity-Induced Hypertension Hypertension, February 1, 2001; 37(2): 554 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rodriguez-Porcel, J. D. Krier, A. Lerman, P. F. Sheedy II, J. C. Romero, C. Napoli, and L. O. Lerman Combination of Hypercholesterolemia and Hypertension Augments Renal Function Abnormalities Hypertension, February 1, 2001; 37(2): 774 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Beswick, H. Zhang, D. Marable, J. D. Catravas, W. D. Hill, and R. C. Webb Long-Term Antioxidant Administration Attenuates Mineralocorticoid Hypertension and Renal Inflammatory Response Hypertension, February 1, 2001; 37(2): 781 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Schachinger, M.B. Britten, S. Dimmeler, and A.M. Zeiher NADH/NADPH oxidase p22 phox gene polymorphism is associated with improved coronary endothelial vasodilator function Eur. Heart J., January 1, 2001; 22(1): 96 - 101. [Abstract] [PDF] |
||||
![]() |
D Tousoulis, C Tentolouris, T Crake, G Goumas, C Stefanadis, P Toutouzas, and G Davies Complex stenosis morphology and vasomotor responses to inhibition of nitric oxide synthesis Heart, November 1, 2000; 84(5): 529 - 534. [Abstract] [Full Text] |
||||
![]() |
S. H. Hohnloser Prevention of recurrent life-threatening arrhythmias: will lipid-lowering therapy make a difference? J. Am. Coll. Cardiol., September 1, 2000; 36(3): 773 - 775. [Full Text] [PDF] |
||||
![]() |
K. M. Channon, H. Qian, and S. E. George Nitric Oxide Synthase in Atherosclerosis and Vascular Injury : Insights From Experimental Gene Therapy Arterioscler. Thromb. Vasc. Biol., August 1, 2000; 20(8): 1873 - 1881. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Kaufmann, T. Gnecchi-Ruscone, K. P. Schafers, T. F. Luscher, and P. G. Camici Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia J. Am. Coll. Cardiol., July 1, 2000; 36(1): 103 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. G. Stroes, E. E. van Faassen, M. Yo, P. Martasek, P. Boer, R. Govers, and T. J. Rabelink Folic Acid Reverts Dysfunction of Endothelial Nitric Oxide Synthase Circ. Res., June 9, 2000; 86(11): 1129 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Somers, K. Mavromatis, Z. S. Galis, and D. G. Harrison Vascular Superoxide Production and Vasomotor Function in Hypertension Induced by Deoxycorticosterone Acetate-Salt Circulation, April 11, 2000; 101(14): 1722 - 1728. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tanaka, M. Kurabayashi, Y. Aihara, Y. Ohyama, and R. Nagai Inducible Expression of Manganese Superoxide Dismutase by Phorbol 12-Myristate 13-Acetate Is Mediated by Sp1 in Endothelial Cells Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 392 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Hein, J. C. Liao, and L. Kuo oxLDL specifically impairs endothelium-dependent, NO-mediated dilation of coronary arterioles Am J Physiol Heart Circ Physiol, January 1, 2000; 278(1): H175 - H183. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Anderson Assessment and treatment of endothelial dysfunction in humans J. Am. Coll. Cardiol., September 1, 1999; 34(3): 631 - 638. [Full Text] [PDF] |
||||
![]() |
J. Y. Jeremy, D. Rowe, A. M. Emsley, and A. C. Newby Nitric oxide and the proliferation of vascular smooth muscle cells Cardiovasc Res, August 15, 1999; 43(3): 580 - 594. [Full Text] [PDF] |
||||
![]() |
M. M. Tarpey, C. R. White, E. Suarez, G. Richardson, R. Radi, and B. A. Freeman Chemiluminescent Detection of Oxidants in Vascular Tissue : Lucigenin But Not Coelenterazine Enhances Superoxide Formation Circ. Res., May 28, 1999; 84(10): 1203 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wever, P. Boer, M. Hijmering, E. Stroes, M. Verhaar, J. Kastelein, K. Versluis, F. Lagerwerf, H. van Rijn, H. Koomans, et al. Nitric Oxide Production Is Reduced in Patients With Chronic Renal Failure Arterioscler. Thromb. Vasc. Biol., May 1, 1999; 19(5): 1168 - 1172. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Schmalfuss, L. Y. Chen, J. N. Bott, E. D. Staples, and J. L. Mehta Superoxide Anion Generation, Superoxide Dismutase Activity, and Nitric Oxide Release in Human Internal Mammary Artery and Saphenous Vein Segments Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1999; 4(4): 249 - 257. [Abstract] [PDF] |
||||
![]() |
I. Kurose, R. E. Wolf, M. B. Grisham, and D. N. Granger Hypercholesterolemia Enhances Oxidant Production in Mesenteric Venules Exposed to Ischemia/Reperfusion Arterioscler. Thromb. Vasc. Biol., October 1, 1998; 18(10): 1583 - 1588. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Hein and L. Kuo LDLs Impair Vasomotor Function of the Coronary Microcirculation : Role of Superoxide Anions Circ. Res., August 24, 1998; 83(4): 404 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Van Belle, C. Bauters, T. Asahara, and J. M. Isner Endothelial regrowth after arterial injury: from vascular repair to therapeutics Cardiovasc Res, April 1, 1998; 38(1): 54 - 68. [Full Text] [PDF] |
||||
![]() |
A. Nitenberg, F. Paycha, S. Ledoux, R. Sachs, J.-R. Attali, and P. Valensi Coronary Artery Responses to Physiological Stimuli Are Improved by Deferoxamine but not by L-Arginine in Non–Insulin-Dependent Diabetic Patients With Angiographically Normal Coronary Arteries and No Other Risk Factors Circulation, March 3, 1998; 97(8): 736 - 743. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Lorgeril Dietary arginine and the prevention of cardiovascular diseases Cardiovasc Res, March 1, 1998; 37(3): 560 - 563. [Full Text] [PDF] |
||||
![]() |
J. S. Luoma, P. Stralin, S. L. Marklund, T. P. Hiltunen, T. Sarkioja, and S. Yla-Herttuala Expression of Extracellular SOD and iNOS in Macrophages and Smooth Muscle Cells in Human and Rabbit Atherosclerotic Lesions : Colocalization With Epitopes Characteristic of Oxidized LDL and Peroxynitrite-Modified Proteins Arterioscler. Thromb. Vasc. Biol., February 1, 1998; 18(2): 157 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. FARACI and D. D. HEISTAD Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels Physiol Rev, January 1, 1998; 78(1): 53 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hoshida, N. Yamashita, J. Igarashi, K. Aoki, T. Kuzuya, and M. Hori Long-term Probucol Treatment Reverses the Severity of Myocardial Injury in Watanabe Heritable Hyperlipidemic Rabbits Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2801 - 2807. [Abstract] [Full Text] |
||||
![]() |
R. H. Boger, S. M. Bode-Boger, R. P. Brandes, L. Phivthong-ngam, M. Bohme, R. Nafe, A. Mugge, and J. C. Frolich Dietary L-Arginine Reduces the Progression of Atherosclerosis in Cholesterol-Fed Rabbits : Comparison With Lovastatin Circulation, August 19, 1997; 96(4): 1282 - 1290. [Abstract] [Full Text] |
||||
![]() |
C. Cardillo, C. M. Kilcoyne, R. O. Cannon III, A. A. Quyyumi, and J. A. Panza Xanthine Oxidase Inhibition With Oxypurinol Improves Endothelial Vasodilator Function in Hypercholesterolemic but Not in Hypertensive Patients Hypertension, July 1, 1997; 30(1): 57 - 63. [Abstract] [Full Text] |
||||
![]() |
H. H. Ting, F. K. Timimi, E. A. Haley, M.-A. Roddy, P. Ganz, and M. A. Creager Vitamin C Improves Endothelium-Dependent Vasodilation in Forearm Resistance Vessels of Humans With Hypercholesterolemia Circulation, June 17, 1997; 95(12): 2617 - 2622. [Abstract] [Full Text] |
||||
![]() |
W. Aji, S. Ravalli, M. Szabolcs, X.-c. Jiang, R. R. Sciacca, R. E. Michler, and P. J. Cannon L-Arginine Prevents Xanthoma Development and Inhibits Atherosclerosis in LDL Receptor Knockout Mice Circulation, January 21, 1997; 95(2): 430 - 437. [Abstract] [Full Text] |
||||
![]() |
O. Tamai, H. Matsuoka, H. Itabe, Y. Wada, K. Kohno, and T. Imaizumi Single LDL Apheresis Improves Endothelium-Dependent Vasodilatation in Hypercholesterolemic Humans Circulation, January 7, 1997; 95(1): 76 - 82. [Abstract] [Full Text] |
||||
![]() |
N. Inoue, S. Ramasamy, T. Fukai, R. M. Nerem, and D. G. Harrison Shear Stress Modulates Expression of Cu/Zn Superoxide Dismutase in Human Aortic Endothelial Cells Circ. Res., July 1, 1996; 79(1): 32 - 37. [Abstract] [Full Text] |
||||
![]() |
C. A. Hathaway, D. D. Heistad, D. J. Piegors, and F. J. Miller Jr Regression of Atherosclerosis in Monkeys Reduces Vascular Superoxide Levels Circ. Res., February 22, 2002; 90(3): 277 - 283. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |